No Data
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Pfizer Options Spot-On: On October 2nd, 70,055 Contracts Were Traded, With 2.8 Million Open Interest
J&J Prostate Cancer Therapy Outperforms in Real-world Study
Zacks Investment Ideas Feature Highlights: Coca-Cola, Pfizer and Altria
Eli Lilly and Co (LLY.US) explores new uses for "miracle weight-loss drug" Zepbound, aiming to reduce the incidence of diabetes and other high-risk populations.
eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.
Health Care Drops on Regulatory Fears - Health Care Roundup
No Data
No Data
Deep Sea OP : The company will have more cash on hand![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
70523852 : Why sold so much shares?
70523852 : I guess my question is why would PFE want to sell so much shares of HLN. HLN still offers dividends. Since they sold them, wouldn’t that lower their future income? I can’t find any explanation on the purpose behind such a huge sell.
Deep Sea OP 70523852 : HLN got low dividend yield of less than 2%. Maybe PFE needs some cash to fund future acquisition of other companies.
70523852 Deep Sea OP : Got it.
Thank you!
View more comments...